1. |
Lavandeira A. Orphan drugs: legal aspects, current situation[J]. Haemophilia, 2002, 8(3): 194-198. DOI: 10.1046/j.1365-2516.2002.00643.x.
|
2. |
Liu J, Barrett JS, Leonardi ET, et al. Natural history and real-world data in rare diseases: applications, limitations, and future perspectives[J]. J Clin Pharmacol, 2022, 2(Suppl 2): S38-55. DOI: 10.1002/jcph.2134.
|
3. |
Cunha-Vaz J, Bernardes R, Lobo C. Blood-retinal barrier[J]. Eur J Ophthalmol, 2011, 21(Suppl 6): S3-9. DOI: 10.5301/EJO.2010.6049.
|
4. |
Vingolo EM, Mascolo S, Miccichè F, et al. Retinitis pigmentosa: from pathomolecular mechanisms to therapeutic strategies[J]. Medicina (Kaunas), 2024, 60(1): 189. DOI: 10.3390/medicina60010189.
|
5. |
Elhannati R, Tahri H. Fundus albipunctatus[J]. Pan Afr Med J, 2016, 23: 61. DOI: 10.11604/pamj.2016.23.61.8562.
|
6. |
Poli FE, MacLaren RE, Cehajic-Kapetanovic J. Retinal patterns and the role of autofluorescence in choroideremia[J/OL]. Genes (Basel), 2024, 15(11): 1471[2024-11-14]. https://pubmed.ncbi.nlm.nih.gov/39596671/. DOI: 10.3390/genes15111471.
|